Group 1 - The core announcement is that Brainstorm Cell Therapeutics has completed a share placement and a rights offering, raising approximately HKD 500.68 million for various strategic purposes [1] - The share placement involved the issuance of 92 million shares at HKD 5.6 per share to at least six independent third-party subscribers, completed on January 27 [1] - The rights offering, which also involved the issuance of 92 million new shares at the same price, was completed on February 5 [1] Group 2 - Following the transactions, the total number of shares for Brainstorm increased from 1.266278 billion to 1.358278 billion [1] - The ownership percentages of concerted parties, other non-public shareholders, and public shareholders have been adjusted as a result of the share issuance [1] - The net proceeds from the offerings are intended for research and development plans, market development, strategic investments, acquisitions, and to supplement working capital [1]
脑动极光完成配售及先旧后新认购 净筹5.01亿港元